Verition Fund Management LLC Alnylam Pharmaceuticals, Inc. Transaction History

Verition Fund Management LLC

$17.4 Billion
Q3 2024

A detailed history of Verition Fund Management LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 17,468 shares of ALNY stock, worth $4.43 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

17,468

Previous 7,415 135.58%

Holding current value

$4.43 Million

Previous $1.8 Million 166.8%

% of portfolio

0.03%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$233.81 - $287.01 $2.35 Million - $2.89 Million	10,053 Added 135.58%	17,468 $4.81 Million
Q2 2024 Aug 14, 2024	BUY	$143.31 - $247.0 $432,652 - $745,693	3,019 Added 68.68%	7,415 $1.8 Million
Q1 2024 May 14, 2024	BUY	$146.51 - $198.2 $644,057 - $871,287	4,396 New	4,396 $656,000
Q3 2023 Nov 14, 2023	BUY	$170.77 - $211.65 $237,541 - $294,405	1,391 New	1,391 $246,000
Q3 2022 Nov 14, 2022	BUY	$138.54 - $232.0 $668,732 - $1.12 Million	4,827 New	4,827 $966,000
Q2 2022 Aug 15, 2022	SELL	$120.42 - $169.29 $289,489 - $406,973	-2,404 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$127.18 - $173.91 $633,610 - $866,419	-4,982 Reduced 67.45%	2,404 $393,000
Q4 2021 May 03, 2022	SELL	$159.56 - $209.29 $781,844 - $1.03 Million	-4,900 Reduced 39.88%	7,386 $1.25 Million
Q4 2021 Feb 14, 2022	BUY	$159.56 - $209.29 $1.79 Million - $2.35 Million	11,218 Added 1050.37%	12,286 $2.08 Million
Q3 2021 Nov 15, 2021	BUY	$169.75 - $207.73 $181,293 - $221,855	1,068 New	1,068 $202,000
Q3 2020 Nov 16, 2020	SELL	$121.19 - $165.49 $211,234 - $288,449	-1,743 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$104.21 - $156.44 $181,638 - $272,674	1,743 New	1,743 $258,000
Q1 2020 May 15, 2020	SELL	$93.12 - $133.99 $493,908 - $710,682	-5,304 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$74.51 - $124.23 $395,201 - $658,915	5,304 New	5,304 $611,000
Q3 2019 Nov 14, 2019	SELL	$70.9 - $87.82 $866,539 - $1.07 Million	-12,222 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$65.86 - $92.79 $804,940 - $1.13 Million	12,222 New	12,222 $887,000
Q3 2018 Nov 15, 2018	SELL	$87.52 - $122.67 $388,238 - $544,164	-4,436 Closed	0 $0
Q2 2018 Aug 15, 2018	SELL	$88.31 - $107.8 $89,811 - $109,632	-1,017 Reduced 18.65%	4,436 $437,000
Q1 2018 May 16, 2018	BUY	$115.92 - $148.54 $632,111 - $809,988	5,453 New	5,453 $649,000

Others Institutions Holding ALNY

# of Institutions

644

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.2B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.

Account

Verition Fund Management LLC Alnylam Pharmaceuticals, Inc. Transaction History